Cyprus vs India: Share of S. aureus infections resistant to methicillin
Cyprus
55.9%
in 2022
India
54.9%
in 2022
Cyprus rank
5th
India rank
7th
Share of S. aureus infections resistant to methicillin over time
- Cyprus
- India
How they compare
Cyprus currently reports 55.9% against 54.9% in India, a difference of 1.0%.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was India ahead.
Cyprus ranks 5th and India ranks 7th of 45 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57.1% | 58.7% | 1.6% | India |
| 2020s | 49.5% | 58.4% | 8.9% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Cyprus or India?
- Cyprus, at 55.9% against 54.9% in India as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Cyprus and India?
- 1.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and India?
- 6 years are reported by both, from 2017 to 2022.
- How do Cyprus and India rank globally for share of s. aureus infections resistant to methicillin?
- Cyprus ranks 5th and India ranks 7th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).